Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04788017
Status:
COMPLETED
Last Update Posted:
2022-02-15
First Post:
2021-02-01
Brief Title:
A Study Evaluating the Safety Tolerability and Pharmacokinetics of Ziresovir in Healthy Subjects
Sponsor:
Shanghai Ark Biopharmaceutical Co Ltd
Organization:
Shanghai Ark Biopharmaceutical Co Ltd
Organization Data
Organization:
Shanghai Ark Biopharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
AK0529-3001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Ark Biopharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None